Division of Hematology & Hematologic Malignancies

The scientific focus of our division is the study of blood and bone marrow in health and disease. Our physicians treat patients with blood cancer, such as leukemias and lymphomas; clotting disorders, such as hemophilia; and diseases of iron metabolism, such as hemochromatosis. Starting with Maxwell Wintrobe, one of the founding fathers of Hematology and the University of Utah Medical School, our division can look back at a long-standing tradition of excellence in research, clinical care and teaching.

Last year researchers from our division garnered more than $7,000,000 in grant income, presented their data at major conferences, and published their results in prime international journals. This would not be possible without the University of Utah’s outstanding collaborative environment and its strong scientific foundation.

Latest News

Education, Research
Mar 03, 2017

2nd Annual Cancer Immunotherapy Conference

The University of Utah School of Medicine is sponsoring a one-day conference on March 25, 2017 on cancer immunotherapy that will bring together basic researchers and clinicians with an interest in immunotherapies as promising approaches for patients with different types of cancer. The conference will provide an update on the most recent developments in the field of cancer immunotherapy and it will facilitate collaborative efforts between basic tumor immunologists and oncologists/hematologists using novel immunotherapeutic approaches to the benefit of their patients. This conference will help us to identify the most promising immunotherapies for our patients leading to improved outcomes and maybe even cures.... Read More

Internal Medicine
7th Annual Hematology Review
Education, Research
Jan 10, 2017

7th Annual Hematology Review

The Seventh Annual Hematology Review conference will take place February 11, 2017 at the Huntsman Cancer Institute, and will feature keynote speaker Jerald Radich, MD, of the Fred Hutchinson Cancer Research Center.... Read More

Internal Medicine
Dec 14, 2016

Congratulations to 2016 ASH Junior Presenters

Congratulations to Hematology faculty and trainees who had delivered presentations at the December 2016 ASH meeting in San Diego CA. Drs. Halwani and Stephens presented their clinical trials research on lymphoma. Clinical Fellow Dr. Ami Patel presented a lecture entitled, "Oral-34: Stroma-Based Activation of pSTAT3Y705 Confers Resistance to FLT3 Inhibitors in FLT3 ITD-Positive AML". Two post-doctoral fellows in the laboratory of Drs. Deininger and O'Hare Dr. Anna Eiring and Dr. Dongqing Yan delivered presentations entitled, " Oral-34: Stroma-Based Activation of pSTAT3Y705 Confers Resistance to FLT3 Inhibitors in FLT3 ITD-Positive AML" and " Oral-636: Selective Inhibition of Nuclear Cytoplasmic Transport As a New Treatment Paradigm in Myelofibrosis", respectively. ... Read More

Internal Medicine



Welcome to the Division of Hematology and Hematologic Malignancies! The scientific focus of our Division is the study of blood and bone marrow in health and disease.

Read More

Bi-Annual Report 2013-14

cover of report

Help Progress, Give Today

You can help the Division of Hematology continue to progress with even a small contribution.

Give Today!